Branhamella catarrhalis is a common cause of otitis media in children and of respiratory infections in adults with chronic bronchitis. Little is known about the antigenic structure of the outer membrane proteins (OMPs). In this study, two murine monoclonal antibodies, 7D6 and 5E8, were developed and used to characterize the major heat-modifiable OMP (OMP C/D) of B. catarrhalis. Immunoblot assays indicated that OMP C/D is heat modifiable, having a molecular mass of 55 kDa at room temperature and a mass of 60 kDa when heated under reducing conditions. Expression of the epitopes is independent of growth phase and growth media. Both epitopes are present in 51 of 51 strains of B. catarrhalis tested and are highly specific for Branhamella strains, being absent from a variety of other gram-negative species. Antibody 5E8 recognizes an epitope which is expressed on the surface of the intact bacterium. We conclude that OMP C/D is a major, heat-modifiable OMP antigen that expresses at least one stable, conserved epitope on the surface of B. catarrhalis. Future studies should focus on the role of OMP C/D in pathogenesis and on its potential role as a vaccine antigen.
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Branhamella catarrhalis has emerged as an important human pathogen in the past decade (5) . The principal site of colonization of B. catarrhalis is the upper respiratory tract, and the organism is predominantly a mucosal pathogen. It is the third most common cause of otitis media in infants and children after nontypeable Haemophilus influenzae and Streptococcus pneumoniae (5, 19) . Based on recent prospective studies utilizing cultures of middle ear fluid obtained by tympanocentesis, B. catarrhalis causes approximately 20% of cases of otitis media (3, 15, 27, 31) . The incidence of otitis media caused by B. catarrhalis is increasing. As strategies for preventing otitis media caused by pneumococcus and nontypeable H. influenzae are developed, the relative importance ofB. catarrhalis as a cause of otitis media will increase in the next decade.
B. catarrhalis is also an important cause of lower respiratory tract infections in adults, particularly in the setting of chronic bronchitis and emphysema (6, 12, 17, 24, 25, 29, 34) . The bacterium causes pneumonia and purulent exacerbations of chronic bronchitis. Finally, B. catarrhalis causes sinusitis in children and adults (4, 9, 30, 32, 33) and occasionally causes invasive disease (7, 8, 10, 11, 13, 26) .
The emergence of B. catarrhalis as an important human pathogen has stimulated interest in studies of the outer membrane proteins (OMPs) of the organism. Studies of OMPs are important to identify virulence factors, to elucidate structure-function relationships in the outer membrane, to characterize surface antigens, and to understand the immune response to infection. Recent studies have begun to shed light on the basic characteristics of the OMPs of B. catarrhalis (2, 20, 23, 28 21 and 28, -45 ,ug with no adjuvant, intraperitoneally. For both the 7D6 and 5E8 fusions, the mice were sacrificed on day 32 after the initial injection, and the spleens were removed and perfused to collect splenocytes. A modification of the procedure of Kennett (14) and our previously described method (1) was used for the fusion. Briefly, splenocytes and Sp210-Agl4 plasmacytoma cells were centrifuged together in a 5:1 ratio at 170 x g for 10 min. The resulting pellet was loosened gently, and 1 ml of 50% polyethylene glycol in 0.075 M HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) (Boehringer Mannhein Biochemicals, Indianapolis, Ind.) was slowly added at room temperature and incubated for 1 min. The concentration of polyethylene glycol was then diluted by the sequential addition of Dulbecco's modified Eagle medium over 7 min. Finally, 8 ml of Dulbecco's modified Eagle medium plus 20% heat-inactivated fetal bovine serum was added, and the suspension was centrifuged at 200 x g for 10 min at 27°C. The supernatant was completely removed, and the cells were suspended in Dulbecco's modified Eagle medium plus 20% fetal bovine serum with supplements at 3 x 105 plasmacytoma cells per ml. Aliquots of 0.05 ml were placed into each well of 96-well microtiter plates. On the day following the fusion, 0.05 ml of HAT medium containing hypoxanthine (13.6 ,g/ml), aminopterin (0.36 ,g/ml), and thymidine (3.9 ,ug/ml) was added. Microtiter plates were incubated under 5% CO2 and 95% humidity at 35°C. Wells were examined for the presence of clones after 2 weeks.
Screening of hybridomas. Whole-cell lysate, Zwittergentextracted outer membrane, and Triton-insoluble fractions were prepared from the homologous strains as previously described (21, 23) . Tissue culture supernatants from hybridomas were screened initially by immunodot assays with these three preparations of the homologous strain. The antigen preparations were dotted onto nitrocellulose, air dried and incubated in 5% nonfat dry milk in buffer A (0.01 M Tris, 0.15 M NaCl, pH 7.4) for 1 h. The nitrocellulose was washed with buffer A and overlaid with tissue culture supernatant from hybridomas and incubated overnight at room temperature. The nitrocellulose was washed and incubated in a 1:1,000 dilution of goat anti-mouse immunoglobulin G (IgG)-IgM-IgA peroxidase-labeled conjugate (Kirkegaard & Perry Laboratories, Gaithersburg, Md.) for 1 h at room temperature. The immunodot assays were developed with horseradish peroxidase color developer as previously described (22) . A positive control for each assay included polyclonal mouse antiserum recovered from the mice whose splenocytes were used in the fusions. Three negative controls for each assay included (i) Sp2/0-Agl4 tissue culture supernatant in place of hybridoma supernatant, (ii) buffer A in place of tissue culture supernatant, and (iii) buffer A in place of the peroxidase conjugate.
After antibodies 7D6 and 5E8 were identified as described in the Results, the hybridomas were cloned by limiting dilution and the isotypes were determined by using the Mono Ab ID EIA kit (Zymed Laboratories, Inc., San Francisco, Calif.). Ascites fluid was prepared by injecting hybridoma cells into the peritoneums of pristane-primed BALB/c mice, and the fluid was collected 2 to 4 weeks later.
SDS-PAGE and immunoblot assays. Samples were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on 11% separating gels with 3% stacking gels and were either stained with Coomassie blue or subjected to immunoblot assays by previously described methods (22) . Once the antigens were transferred to nitrocellulose, the immunoblot assays were performed as described above for the immunodot assays.
Immunoadsorption experiments. To determine whether the antibodies recognize epitopes that are expressed on the surface of the intact bacterium, we used the immunoadsorption method of Loeb (16) . Tissue culture supematants were precipitated with ammonium sulfate by standard methods before these experiments were performed. The ammonium sulfate-precipitated antibodies were tested at various dilutions in an immunodot assay with whole-cell lysates to determine the dilution at which to perform the adsorptions.
Bacteria were grown in broth to the mid-logarithmic phase and harvested by centrifugation at 5,000 x g for 15 min. Cells were suspended in phosphate-buffered saline with 0.5 mM MgCl2 plus 0.15 mM CaCJ2 added (PCM). The equivalent of 50 ml of cells was gently suspended in 0.8 ml of PCM. To this suspension was added 0.8 ml of diluted monoclonal antibodies which were then gently mixed. The suspensions were incubated at room temperature for 60 min with occasional mixing. Cells were centrifuged, and the adsorbed antibody preparations were tested in immunoblot assays. To control for the possibility that antibodies might adhere nonspecifically to bacteria, aliquots of the antibodies were also adsorbed with a strain of Kingella denitrificans and a strain of Escherichia coli. These bacteria do not express the epitopes recognized by 7D6 and 5E8.
Immunofluorescence. To further assess whether the antibodies recognized epitopes that are expressed on the surface of the intact bacterium, we performed immunofluorescence assays. Bacterial cells were harvested from an agar plate, suspended in 0.9% sodium chloride, placed on printed slides, and allowed to air dry. A volume of 0.05 ml of tissue culture supernatant was placed on each section of the slide and incubated for 1 h at room temperature. After the slides were thoroughly washed with 0.9% NaCl plus 0.05% Tween 20, goat anti-mouse Ig conjugated to fluorescein was placed on the slide and incubated for 30 Figure 1 shows a gel and immunoblot assay of Zwittergentextracted outer membrane of B. catarrhalis 4223 in which two lanes were stained with Coomassie blue and four lanes were transferred onto nitrocellulose and probed with antibodies 7D6 and 5E8. In the samples which were solubilized at room temperature in the absence of 3-mercaptoethanol, a broad band of approximately 55 kDa is apparent. In the samples solubilized at 100°C in the presence of ,B-mercaptoethanol, a double band of approximately 60 kDa is detected. The molecular mass and heat modifiability of the bands art characteristic of OMP C/D. Furthermore, since the Zwittergent extract is free of cellular components other than outer membrane (21) , and since bands other than C/D are not apparent in the Zwittergent extract in this molecular mass range, we conclude that antibodies 7D6 and 5E8 are directed against OMP C/D.
The molecular mass of OMP C/D was determined by measurement of the Rf and calculation from standard curves with molecular mass standards. This was performed on four separate gels. Based on these measurements, the heatmodified form of OMP C/D is approximately 60 kDa and the non-heat-modified form is approximately 55 kDa. These sizes for OMP C/D are somewhat lower than previous measurements which were based on standard curves from a previous series of gels (2) . This difference appears to be a result of variability in mobility of proteins in SDS-PAGE Surface exposure of the epitopes recognized by antibodies 7D6 and 5E8. To determine whether antibodies 7D6 and 5E8 recognize epitopes that are expressed on the surface of the intact bacterium, aliquots of antibodies were adsorbed with whole bacterial cells, and the resulting adsorbed antibody preparations were tested in immunoblot assays. In this assay, disappearance or decrease in the intensity of the band compared with unadsorbed antibody indicates that the antibody binds to an epitope that is present on the bacterial surface. Figure 3 shows that adsorption of antibody 7D6 with B. catarrhalis 4223 and 5191 causes a decrease in the intensity of the bands compared with unadsorbed antibody. Adsorption of antibody 5E8 causes a complete disappearance of the bands compared with unadsorbed antibody. The specificity of this observation is confirmed by the persistence of the bands in aliquots of the antibodies which were adsorbed with K denitnificans F8841 and E. coli Y1090, two strains which do not express the 7D6 and 5E8 epitopes (lanes d and e). We conclude that the epitope recognized by antibody 5E8 is expressed on the surface of the intact bacterium. The epitope recognized by antibody 7D6 may be partially exposed on the bacterial surface, but it is difficult to draw definitive conclusions regarding the surface exposure of this epitope based on these experiments.
To further assess the question of surface exposure, we tested antibodies 7D6 and 5E8 with strains 4223 and 5191 in an indirect immunofluorescence assay. Antibody 5E8 produced prominent fluorescence of cells of both strains (Fig.  4) . Antibody 7D6 yielded equivocal results. Three controls included (i) Sp2/0-Agl4 tissue culture supematant in place of antibody (Fig. 4) , (ii) buffer in place of antibody, and (iii) K denitnficans F8841 as the organism on the slide. Antibody tween control and experimental wells was not possible. By contrast, all experiments involving 5E8 produced prominent staining, and the difference between experimental and control assays was obvious.
Competitive immunodot assays. To determine whether antibodies 7D6 and 5E8 recognized different epitopes on the C/D protein, we dotted Zwittergent-extracted outer membranes of strain 4223 onto nitrocellulose. After blocking, the antigens were incubated with antibody 5E8 for 8 h. Following washing, the antigens were then incubated with antibody 7D6 for 16 h. Binding of antibody 7D6 to its epitope was then detected with protein A-peroxidase and horseradish peroxidase color developer. Figure 5 shows the results. Preincubation of outer membrane with antibody 5E8 does not inhibit the binding of antibody 7D6 to its epitope. Similarly, the (Fig. 2) . Second, the species specificity of antibodies 7D6 and 5E8 is different (Table 1) . Third, the surface exposure of the two antibodies is different ( Fig. 3 and 4) . Finally, preincubation of immunodot assays with one antibody does not block the binding of the other antibody (Fig. 5) Antibody 5E8 recognizes an epitope that is expressed on the surface of the intact bacterium and that is conserved among all strains of B. catarrhalis tested. Indeed, the strikingly prominent signal in immunofluorescence assays (Fig. 4) and the complete adsorption of antibody 5E8 by intact bacterial cells (Fig. 3) suggest that the epitope is abundantly expressed on the bacterial surface. This observation has important implications with regard to identifying potential vaccine antigens. The presence of a conserved, surface-exposed epitope suggests that OMP C/D generates protective antibody. Future studies will evaluate the role of the C/D protein in the human immune response to infection and assess the potential role of antibody to OMP C/D in protection from infection.
In summary, the present study establishes that OMP C/D is present in all strains of B. catarrhalis and has a molecular mass that is identical in all strains tested. Based on SDS-PAGE of purified outer membrane, OMP C/D appears to be the most abundant protein in the outer membrane (Fig. 1 ). This 
